Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-04-26

Clinical Trial Update: A Trial of Ribavirin in Patients With ACLF Due to Hepatitis E Virus [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating ribavirin in patients with acute-on-chronic liver failure due to Hepatitis E virus. The status o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ribavirin (ribavirin)

Snippet

Sponsor: All India Institute of Medical Sciences | Conditions: Acute on Chronic Hepatic Failure, Liver Failure | Phase 2 | Status: UNKNOWN